Showing posts with label Diabetes Mellitus. Show all posts
Showing posts with label Diabetes Mellitus. Show all posts
Wednesday, May 13, 2020
Signs of insulin resistance or conditions associated with insulin resistance
• acanthosis nigricans
• Hypertension
• Dyslipidemia
• PCOS
• birth weight small for gestational age
Diabetes Risk factors in overweight children
obesity = (BMI >85th percentile for age and sex, weight for
height >85th percentile, or weight >120% of ideal for height)
• FH of type2 DM in first- or second-degree relative
• Race/ethnicity
• Signs of insulin resistance or conditions associated with insulin resistance
• Maternal history of diabetes or GDM during child’s gestation
• Age of initiation: 10 years or at onset of puberty, if puberty occurs at a younger age
• Frequency: every 3 years
• FH of type2 DM in first- or second-degree relative
• Race/ethnicity
• Signs of insulin resistance or conditions associated with insulin resistance
• Maternal history of diabetes or GDM during child’s gestation
• Age of initiation: 10 years or at onset of puberty, if puberty occurs at a younger age
• Frequency: every 3 years
التسميات:
Diabetes Mellitus,
Over Weight,
Overweight Children
Categories of increased risk for diabetes prediabetes
FPG 100 me/dl (5.6 mmol/L) to 125 mg/dL (6.9 mmol/L) (IFG)
OR
2-h PG in the 75-g OGTT 140 mg/dL (7.8 mmol/L) to 199 mg/dL (11.0 mmol/L} (IGT)
OR
A1C 5.7-6.4% (39-46 mmol/mol)
*For all three tests, risk is continuous, extending below the lower limit of the range and
becoming disproportionately greater at the higher end of the range.
¢ A1C between 5.7 and 6.0% had a substantially
increased risk of diabetes with 5-year incidences
ranging from 9-25%.
¢ An A1C range of 6.0 to 6.5% had a 5-year risk of
developing diabetes between 25 to 50% and relative
risk 20 times higher compared with an AlCof 5.0%
Wednesday, May 6, 2020
Additional Risk factors in Patients with Diabetes Mellitus
Additional Risk Factors
Decreased Physical Activity
First Degree Relative with Diabetes Mellitus
High Risk Race or Ethinity
Women who was diagnosed with Gestational DM
Hypertension or Therapy for HTN
HDL Cholesterol level below 35 mg/dl or triglycrides over 250 mg/dl
Women with poly cystic ovary disease PCOD
HBA1C more than 5.7
Clinical conditions associated with increased Insulin Resistance
History of Cardiovascular Disease
Recommended treatment for Metabolic Syndrome
• Preventing the development of type 2 DM and
coronary vascular disease.
• Focus on lifestyle modifications (diet, weight loss, exercise),
• if needed, medication for treatment of insulin resistance.
• Focus on lifestyle modifications (diet, weight loss, exercise),
• if needed, medication for treatment of insulin resistance.
Guidelines for Screening for Type 2 Diabetes
Testing to assess risk for future diabetes in asymptomatic people should be considered in adults of any age who are overweight or obese (BMI ≥ 25 kg/m2 or ≥ 23 kg/m2 in Asian Americans) and who have one or more additional risk factors for diabetes.• For all patients, testing should begin at age 45 years.
If tests are normal, repeat test at a minimum of 3- year intervals.
To test for prediabetes, fasting plasma glucose, 2-h
plasma glucose after 75-g oral glucose tolerance test,
and A1C are equally appropriate.
In patients with prediabetes, identify and treat other
cardiovascular disease risk factors. •
Testing should be considered in children and
adolescents who are overweight or obese and who
have two or more additional risk factors for diabetes
Why we have to lose Weight asap ?
Saturday, May 2, 2020
Metabolic Syndrome Insulin resistance syndrome – Syndrome X
• A combination of insulin resistance and ↑ risk of 2 DM
Diagnosis is based on any 3 of the following Adult
Treatment Panel III criteria
Abdominal obesity waist circumference > 40 inches in
men, > 35 inches in women
TG ≥ 150 mg/dL
HDL < 40 mg/dL in men and < 50 mg/dL in women
BP ≥ 130/85 mmHg
Fasting glucose ≥ 110 mg/dL
Treatment
• Preventing the development of type 2 DM and
coronary vascular disease
.
• Focus on lifestyle modifications (diet, weight loss,
exercise)
,
• if needed, medication for treatment of insulin
resistance
Advantages and Disadvantages of HB A1C test for Diagnosis of Diabetes Mellitus DM
Advantages and Disadvantages of HB A1C test for Diagnosis of Diabetes Mellitus DM
Other Disadvantages due to inaccuracy in some medical conditions
anemia and hemo-globinopathies.
Conditions with abnormal red cell turnover, such
as:
Pregnancy
Recent blood loss
Blood transfusion
Perform A1C 2 times yearly in Stable patients meeting treatment goals
Perform A1C every 3 months for unstable patients
A1C between 5.7 and 6.0% had a substantially
increased risk of diabetes with 5-year incidences
ranging from 9–25
An A1C range of 6.0 to 6.5% had a 5-year risk of developing diabetes between 25 to 50% and relative risk 20 times higher compared with an A1Cof 5.0%
An A1C range of 6.0 to 6.5% had a 5-year risk of developing diabetes between 25 to 50% and relative risk 20 times higher compared with an A1Cof 5.0%
Diagnosis of Diabetes Mellitus
Click the image for Better View
If two different tests (such as A1C and FPG) are both
above the diagnostic thresholds, the diagnosis of
diabetes is confirmed
If the results of two different tests are discordant, the
test whose result is above the diagnostic cut point
should be repeated, and the diagnosis is made on the
basis of the confirmed test
Definition & Classification of Diabetes Mellitus
Diabetes is a complex, chronic illness requiring
continuous medical care with multifactorial riskreduction strategies beyond glycemic control.
• Ongoing patient self-management education and support are critical to preventing acute
complications and reducing the risk of long-term complications
Diabetes is the 4th or 5th leading cause of death in most developed countries
• Epidemic in developing countries.
One in two adults with diabetes is undiagnosed
One in seven births is affected by gestational diabetes
Classification
Type 1 diabetes (results from b-cell destruction, usually leading to absolute insulin deficiency)
Type 2 diabetes (results from a progressive insulin secretory defect on the background of insulin resistance) 3. Other specific types of diabetes 4. Gestational diabetes mellitus (GDM) (diabetes diagnosed during pregnancy)
Classification Other specific types of diabetes:
. Genetic defects in b-cell function 2. Genetic defects in insulin action
3. Diseases of the exocrine pancreas (such as cystic fibrosis)
4. Drug- or chemical induced (such as in the treatment of HIV/AIDS or after organ transplantation)
• Ongoing patient self-management education and support are critical to preventing acute
complications and reducing the risk of long-term complications
Diabetes is the 4th or 5th leading cause of death in most developed countries
• Epidemic in developing countries.
One in two adults with diabetes is undiagnosed
One in seven births is affected by gestational diabetes
Classification
Type 1 diabetes (results from b-cell destruction, usually leading to absolute insulin deficiency)
Type 2 diabetes (results from a progressive insulin secretory defect on the background of insulin resistance) 3. Other specific types of diabetes 4. Gestational diabetes mellitus (GDM) (diabetes diagnosed during pregnancy)
Classification Other specific types of diabetes:
. Genetic defects in b-cell function 2. Genetic defects in insulin action
3. Diseases of the exocrine pancreas (such as cystic fibrosis)
4. Drug- or chemical induced (such as in the treatment of HIV/AIDS or after organ transplantation)
Subscribe to:
Posts (Atom)